| Literature DB >> 33919028 |
Nadia Ferlazzo1, Antonio Micali1, Herbert Ryan Marini2, Josè Freni1, Giuseppe Santoro1, Domenico Puzzolo1, Francesco Squadrito2, Giovanni Pallio2, Michele Navarra3, Santa Cirmi3,4, Letteria Minutoli2.
Abstract
It is known that cadmium damages testis structure and functionality. We examined the effects of nutraceuticals such as a flavonoid-rich extract of bergamot juice (BJe), alone or in association with curcumin (Cur) and resveratrol (Re), on mice testicular dysfunction caused by cadmium chloride (CdCl2). Controversial data on the protective effects of Cur and Re are available, while no evidence on the possible role of BJe exists. Adult male C57 BL/6J mice were administered with CdCl2 and treated with Cur, Re, or BJe alone or in combination for 14 days. Then, testes were removed and processed for molecular, structural, and immunohistochemical analyses. CdCl2 increased the mRNA of IL-1β, TNF-α, p53, and BAX while reduced that of Bcl-2 and induced tubular lesions and apoptosis of germinal cells. Cur, Re, and BJe at 40 mg/kg significantly improved all of these parameters and events, although BJe at 20 mg/kg showed a lower protective effect. The association of Cur, Re, and BJe at both doses of 50/20/20 and 100/20/40 mg/kg brought each parameter close to those of the control. Our results indicate that the nutraceuticals employed in this study and their associations exert a positive action against Cd-induced testicular injury, suggesting a possible protection of testis functionality in subjects exposed to environmental toxicants.Entities:
Keywords: apoptosis; bergamot juice; cadmium; curcumin; flavonoids; functional food; nutraceuticals; oxidative stress; resveratrol; testis
Year: 2021 PMID: 33919028 PMCID: PMC8142973 DOI: 10.3390/ph14050386
Source DB: PubMed Journal: Pharmaceuticals (Basel) ISSN: 1424-8247
Cur, Re, BJe, and their combinations improved BW, TW, and TW/BW in mice exposed to CdCl2. All values are expressed as mean ± SEM; n = 7 animals for each group.
| BW (g) | TW (mg) | TW/BW | |
|---|---|---|---|
| Controls | 30.2 ± 1.8 | 108.2 ± 9.4 | 3.59 |
| CdCl2 + vehicle | 24.3 ± 1.5 a | 71.2 ± 5.4 a | 2.93 a |
| CdCl2 + Cur 50 mg/kg | 27.1 ± 1.4 a,b | 83.2 ± 5.9 a,b | 3.07 a,b |
| CdCl2 + Cur 100 mg/kg | 27.8 ± 1.6 a,b | 88.9 ± 6.1 a,b | 3.19 a,b |
| CdCl2 + Re 20 mg/kg | 28.9 ± 1.1 b | 94.7 ± 6.5 b | 3.27 b |
| CdCl2 + BJe 20 mg/kg | 25.9 ± 1.4 a | 80.6 ± 5.2 a | 3.11 a |
| CdCl2 + BJe 40 mg/kg | 29.2 ± 1.3 b | 98.4 ± 5.8 b | 3.36 b |
| CdCl2 + Cur 50 mg/kg + Re 20 mg/kg + BJe 20 mg/kg | 28.8 ± 1.2 b | 100.3 ± 5.2 b | 3.48 b |
| CdCl2 + Cur 100 mg/kg + Re 20 mg/kg + BJe 40 mg/kg | 29.8 ± 1.4 b | 105.7 ± 6.1 b | 3.54 b |
ap < 0.05 vs. control; b p < 0.05 vs. CdCl2 + vehicle.
Figure 1Real-time PCR analysis for TNF-α (A) and IL-1β (B). * p < 0.05 versus control mice; § p < 0.05 versus CdCl2-treated mice.
Figure 2Real-time PCR analysis for p53 (A), Bcl-2 (B), and BAX (C). * p < 0.05 versus control mice; § p < 0.05 versus CdCl2-treated mice.
Figure 3Histological organization of the testes evaluated with hematoxylin–eosin stain in different groups of adult male mice (7 mice/group) (scale bar: 50 µm). (A): Control mice. The normal structure of both tubular and extratubular compartments is present. (B): Mice challenged with CdCl2. Testes with discontinuous epithelium and marked edema in the extratubular compartment are present. (C,D): Mice challenged with CdCl2 and treated with Cur at 50 or 100 mg/kg. Tubules with seminiferous epithelium formed by spermatocytes separated from spermatogonia are evident. (E): Testes of CdCl2 plus Re-treated mice. Significantly larger tubules with elongated spermatids can be observed. Extratubular edema is reduced. (F): Testes of CdCl2 plus BJe at 20 mg/kg-treated mice. The germinal epithelium shows many large clefts and many irregularly arranged spermatocytes. Hyperemia is present in the extratubular compartment. (G–I): Testes from mice treated with CdCl2 plus BJe alone at 40 mg/kg and with both the extract associations Cur 50 mg/kg + Re 20 mg/kg + BJe 20 mg/kg and Cur 100 mg/kg + Re 20 mg/kg + BJe 40 mg/kg. In all groups, the germinal epithelium has a normal structure with many spermatids and mature spermatozoa. Additionally, the extratubular compartment shows normal morphological organization. The images are representative of the nine mice from each experimental group. (J): Quantitative evaluation of the mean tubular diameter in the different groups of mice. (K): Johnsen’s score in the different groups of mice. * p < 0.05 versus control; § p < 0.05 versus CdCl2-treated mice.
Figure 4Assessment of apoptosis in mice testes with TUNEL staining technique (scale bar: 50 µm). (A): In control mice, no TUNEL-positive cells can be observed. (B): In the seminiferous epithelium of mice challenged with CdCl2 alone, a large number of peripheral TUNEL-positive germ cells are present. (C): Mice challenged with CdCl2 and treated with Cur at 50 mg/kg. Many TUNEL-positive germ cells are observed. (D): Mice challenged with CdCl2 and treated with Cur at 100 mg/kg. A reduction of TUNEL-positive cells is evident. (E): Mice challenged with CdCl2 and treated with Re. A further reduction in the number of TUNEL-positive cells is evident. (F): CdCl2 plus BJe in 20 mg/kg-treated mice. TUNEL-positive cells are more numerous. (G): In CdCl2 plus BJe alone in 40 mg/kg-treated mice, the number of TUNEL positive cells is significantly reduced. (H,I): In both extract associations Cur 50 mg/kg + Re 20 mg/kg + BJe 20 mg/kg and Cur 100 mg/kg + Re 20 mg/kg + BJe 40 mg/kg-treated mice, isolated or even no TUNEL-positive germ cells are observed in the periphery of the seminiferous tubules. The images are representative of the nine mice of each experimental group. (J): Tubules with apoptotic cells (TWAC) (expressed in %) in the different groups of mice. (K): Apoptotic index (apoptotic cells/tubule) in the different groups of mice. * p < 0.05 versus controls; § p < 0.05 versus CdCl2-treated mice.
Oligonucleotide primers used for the quantitative real-time PCR analyses.
| Genes | Forward Primer Sequences | Reverse Primer Sequences |
|---|---|---|
| BAX | GCGAATTGGAGATGAACT | CAGTTGAAGTTGCCATCA |
| BCL-2 | GTGGAGGAACTCTTCAGG | TGACATCTCCCTGTTGAC |
| P53 | TGGAAGACAGGCAGACTT | ACTTGTAGTGGATGGTGGTA |
| IL-1β | ATCTATACCTGTCCTGTGTAATGA | GCTTGTGCTCTGCTTGTG |
| TNF-α | GTGGAACTGGCAGAAGAG | ATGAGAAGAGGCTGAGACA |
| iNOS | GAGCGAGTTGTGGATTGT | GCAGCCTCTTGTCTTTGA |
| β-ACT | GCTGTGCTATGTTGCTCTA | TCGTTGCCAATAGTGATGA |